Loxo Oncology Inc. (LOXO) Has Jumped To A New High On Study Results

Loxo Oncology Inc. (LOXO) announced after the bell Wednesday that preliminary results from a Phase 1 trial showed that its LOXO-292 drug shrank tumors in nearly 70 percent of patients.

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>